Harman Finochem's Metformin Hydrochloride ANDA218673 Receives AP Status
The FDA has granted approval status (AP) for Harman Finochem's Abbreviated New Drug Application (ANDA218673) for Metformin Hydrochloride.
Asset / Drug
Drug and asset intelligence for Harman with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.